Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

312 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies.
Mattei PL, Corey KC, Kimball AB. Mattei PL, et al. J Eur Acad Dermatol Venereol. 2014 Mar;28(3):333-7. doi: 10.1111/jdv.12106. Epub 2013 Feb 21. J Eur Acad Dermatol Venereol. 2014. PMID: 23425140 Review.
Quantifying the harmful effect of psoriasis on health-related quality of life.
Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emanuel EJ. Weiss SC, et al. J Am Acad Dermatol. 2002 Oct;47(4):512-8. doi: 10.1067/mjd.2002.122755. J Am Acad Dermatol. 2002. PMID: 12271293
Clinical and immunologic assessment of patients with psoriasis in a randomized, double-blind, placebo-controlled trial using recombinant human interleukin 10.
Kimball AB, Kawamura T, Tejura K, Boss C, Hancox AR, Vogel JC, Steinberg SM, Turner ML, Blauvelt A. Kimball AB, et al. Arch Dermatol. 2002 Oct;138(10):1341-6. doi: 10.1001/archderm.138.10.1341. Arch Dermatol. 2002. PMID: 12374540 Clinical Trial.
Quality of life considerations in psoriasis treatment.
Weiss SC, Bergstrom KG, Weiss SA, Kimball AB. Weiss SC, et al. Dermatol Nurs. 2003 Apr;15(2):120, 123-7; quiz 128. Dermatol Nurs. 2003. PMID: 12751346 Review.
Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial.
Feldman SR, Kimball AB, Krueger GG, Woolley JM, Lalla D, Jahreis A. Feldman SR, et al. J Am Acad Dermatol. 2005 Nov;53(5):887-9. doi: 10.1016/j.jaad.2005.06.053. J Am Acad Dermatol. 2005. PMID: 16243150 Clinical Trial.
The psychosocial burden of psoriasis.
Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. Kimball AB, et al. Am J Clin Dermatol. 2005;6(6):383-92. doi: 10.2165/00128071-200506060-00005. Am J Clin Dermatol. 2005. PMID: 16343026 Review.
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.
Menter A, Tyring SK, Gordon K, Kimball AB, Leonardi CL, Langley RG, Strober BE, Kaul M, Gu Y, Okun M, Papp K. Menter A, et al. J Am Acad Dermatol. 2008 Jan;58(1):106-15. doi: 10.1016/j.jaad.2007.09.010. Epub 2007 Oct 23. J Am Acad Dermatol. 2008. PMID: 17936411 Clinical Trial.
From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis.
Lebwohl M, Bagel J, Gelfand JM, Gladman D, Gordon KB, Hsu S, Kalb RE, Kimball AB, Korman NJ, Krueger GG, Mease P, Morison WL, Paller A, Pariser DM, Ritchlin C, Strober B, Van Voorhees A, Weinstein GD, Young M, Horn L. Lebwohl M, et al. J Am Acad Dermatol. 2008 Jan;58(1):94-105. doi: 10.1016/j.jaad.2007.08.030. Epub 2007 Nov 5. J Am Acad Dermatol. 2008. PMID: 17980456
312 results
Jump to page
Feedback